This brand name is authorized in Japan
The drug PICILLIBACTA contains a combination of these active pharmaceutical ingredients (APIs):
1
Sulbactam
UNII DKQ4T82YE6 - SULBACTAM SODIUM
|
|
2
Ampicillin
UNII JFN36L5S8K - AMPICILLIN SODIUM
|
Ampicillin is a broad spectrum penicillin, indicated for the treatment of a wide range of bacterial infections caused by ampicillin sensitive organisms. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
J01CR01 | Ampicillin and enzyme inhibitor | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CR Combinations of penicillins, incl. beta-lactamase inhibitors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 6139504F1103, 6139504F2037, 6139504F3068 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.